5,7-dihydroxy-8-(3-methyl-2-butenyl)coumarin

ID: ALA3596580

Chembl Id: CHEMBL3596580

Cas Number: 53017-21-3

PubChem CID: 71365395

Max Phase: Preclinical

Molecular Formula: C14H14O4

Molecular Weight: 246.26

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)=CCc1c(O)cc(O)c2ccc(=O)oc12

Standard InChI:  InChI=1S/C14H14O4/c1-8(2)3-4-9-11(15)7-12(16)10-5-6-13(17)18-14(9)10/h3,5-7,15-16H,4H2,1-2H3

Standard InChI Key:  LVBKSGLMACQGNB-UHFFFAOYSA-N

Associated Targets(Human)

ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

norA Quinolone resistance protein norA (2171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mdeA Fluoroquinolone resistance protein (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 246.26Molecular Weight (Monoisotopic): 246.0892AlogP: 2.71#Rotatable Bonds: 2
Polar Surface Area: 70.67Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.40CX Basic pKa: CX LogP: 2.90CX LogD: 2.60
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.63Np Likeness Score: 1.96

References

1. Joshi P, Singh S, Wani A, Sharma S, Jain SK, Singh B, Gupta BD, Satti NK, Koul S, Khan IA, Kumar A, Bharate SB, Vishwakarma RA.  (2014)  Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs,  (10): [10.1039/C4MD00196F]

Source